PB2286: INFLUENCE OF ANTI-CD20 MONOCLONAL ANTIBODY THERAPY ON THE OUTCOME OF CORONAVIRUS INFECTION COVID-19 IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES

• E. Zotina,
• E. Zhelnova,
• E. Karimova,
• E. Grishina,
• E. Paramonova,
• D. Gagloeva,
• E. Baryakh,
• E. Misyurina

Affiliations

E. Zotina

1 Hematology, City Clinical Hospital №52, Moscow, Russia

E. Zhelnova

1 Hematology, City Clinical Hospital №52, Moscow, Russia

E. Karimova

1 Hematology, City Clinical Hospital №52, Moscow, Russia

E. Grishina

1 Hematology, City Clinical Hospital №52, Moscow, Russia

E. Paramonova

1 Hematology, City Clinical Hospital №52, Moscow, Russia

D. Gagloeva

1 Hematology, City Clinical Hospital №52, Moscow, Russia

E. Baryakh

1 Hematology, City Clinical Hospital №52, Moscow, Russia

E. Misyurina

1 Hematology, City Clinical Hospital №52, Moscow, Russia